Suchergebnisse - "31YO63LBSN"

PubPharm (5.661)

1

Brief Report : Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von McNamee, N. | Harvey, C. | Gray, L. | +19

2

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer : a phase Ib trial and ctDNA analyses

enthalten in: Nature medicine | 2024

von Kelly, R. | Landon, B. | Zaidi, A. | +28

3

REVOLUMAB : A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Picca, A. | Touat, M. | Belin, L. | +13

4

Immune-related adverse events associated with first-line immune checkpoint inhibitors for metastatic renal cell carcinoma : A systematic review and network meta-analysis

enthalten in: International immunopharmacology | 2024

von Wang, S. | Lv, H. | Yu, J. | +1

5

UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Haakensen, V. | Öjlert, �. | Thunold, S. | +11

6

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

enthalten in: Cancer research communications | 2024

von Yarchoan, M. | Powderly, J. | Bastos, B. | +17

7

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy

enthalten in: Scientific reports | 2024

von Brun, S. | Hansen, T. | Wen, S. | +5

8

Re : Gemcitabine and Cisplatin plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial. Galsky MD, Daneshmand S, Izadmehr S, et al. Nat Med 2023;29:2825-34

enthalten in: European urology | 2024

von Shariat, S. | Laukhtina, E.

9

Re : Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

enthalten in: European urology | 2024

von Moschini, M. | Necchi, A. | Montorsi, F.

10

Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma : A Single-Arm, Phase II Study

enthalten in: Cancer research and treatment | 2024

von Park, S. | Lee, Y. | Lee, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[567]